Bioactivity:

Aristolactam AIIIa is a new type of Plk1 inhibitors, targeting the Polo Box domain (PBD), it has anti-tumor activity. Aristolactam IIIa shows inhibition of platelet aggregation induced by collagen or arachidonic acid.

CAS nr:

97399-91-2

Purity:

98%

Molecular Weight:

281,26

SMILES:

COc1c(O)cc2C(=O)Nc3cc4ccc(O)cc4c1c23

Formula:

C16H11NO4

Pathway:

MAPK,Cell Cycle/Checkpoint

Target:

MAPK,CDK